FDA-NRC Workshop: Targeted Alpha Emitting Radiopharmaceuticals, with Focus on Ac-225 – 09/22/2021 – 09/22/2021

Discussions will include: Targeted Alpha Emitters with Focus on Actinium-225 Radiotherapies; Novel Radiopharmaceuticals: Standards Development, Product Quality Considerations, Supply and Demand; Clinical Considerations for Development of Novel Radiopharmaceuticals; User and Industry Perspective.